Unity Biotechnology, Inc. (UBX)
NASDAQ: UBX · Real-Time Price · USD
1.940
-0.110 (-5.37%)
At close: Feb 21, 2025, 4:00 PM
1.914
-0.026 (-1.36%)
After-hours: Feb 21, 2025, 7:25 PM EST
Unity Biotechnology Employees
Unity Biotechnology had 19 employees as of December 31, 2023. The number of employees decreased by 13 or -40.63% compared to the previous year.
Employees
19
Change (1Y)
-13
Growth (1Y)
-40.63%
Revenue / Employee
n/a
Profits / Employee
-$1,152,105
Market Cap
32.69M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
UBX News
- 6 weeks ago - UNITY Biotechnology Reports Granting of New Employment Inducement Award - GlobeNewsWire
- 6 weeks ago - UNITY Biotechnology Announces Appointment of Federico Grossi, M.D., Ph.D., as Chief Medical Officer - GlobeNewsWire
- 3 months ago - UNITY Biotechnology, Inc. Reports Third Quarter 2024 Financial Results and Business Updates - GlobeNewsWire
- 7 months ago - UNITY Biotechnology, Inc. Reports Second Quarter 2024 Financial Results and Business Updates - GlobeNewsWire
- 7 months ago - UNITY Biotechnology Announces Appointment of Alicia Tozier as Chief Strategy Officer - GlobeNewsWire
- 10 months ago - UNITY Biotechnology, Inc. Reports First Quarter 2024 Financial Results and Business Updates - GlobeNewsWire
- 10 months ago - UNITY Biotechnology Announces Upcoming Presentations at the ARVO 2024 Annual Meeting - GlobeNewsWire
- 10 months ago - UNITY Biotechnology Announces Extension of Phase 2b ASPIRE Clinical Study Evaluating UBX1325 in DME - GlobeNewsWire